Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Leukemia, Myeloid, Chronic-Phase × dabrafenib × Clear all

Sponsor

Conditions

Melanoma 25 Neoplasms 8 Brain Neoplasms 5 Neoplasm Metastasis 3 Skin Neoplasms 2 Glioma 2 Carcinoma, Non-Small-Cell Lung 2 Thyroid Neoplasms 1 Thyroid Carcinoma, Anaplastic 1 Thyroid Cancer, Papillary 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Oligodendroglioma 1 Nonseminomatous germ cell tumor 1 Neurocytoma 1 Multiple Myeloma 1 Leukemia, Hairy Cell 1 Hematologic Neoplasms 1 Glioblastoma 1 Gastrointestinal Stromal Tumors 1 Ganglioneuroma 1 Ganglioglioma 1 Fever 1 Biliary Tract Neoplasms 1 Astrocytoma 1 Ameloblastoma 1 Adamantinoma 1

Interventions

fludarabine phosphate 27 Cyclophosphamide 23 Whole-Body Irradiation 22 Peripheral Blood Stem Cell Transplantation 21 Mycophenolic Acid 21 Cyclosporine 18 Busulfan 18 Tacrolimus 15 Imatinib Mesylate 12 Antilymphocyte Serum 12 Methotrexate 11 Melphalan 10 Dasatinib 10 Cord Blood Stem Cell Transplantation 10 Cyclosporins 8 Etoposide 7 nilotinib 6 Radiotherapy 6 Methylprednisolone 6 Filgrastim 6 Sirolimus 5 Alemtuzumab 5 thymoglobulin 4 bosutinib 4 Granulocyte Colony-Stimulating Factor 4 Cytarabine 4 fludarabine 3 Thiotepa 3 Rituximab 3 Flow Cytometry 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡